Impact of body mass index on surgical and oncological outcomes after Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

QR Code

Impact of body mass index on surgical and oncological outcomes after Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

<h4>Background</h4>Complete cytoreductive surgery with Hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for patients with peritoneal metastases. In this retrospective observational two-center study, we assessed the impact of patient's body mass index (BMI)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anne-Cécile Ezanno, Olivier Poudevigne, Jean-Louis Quesada, Julio Abba, Brice Malgras, Bertrand Trilling, Pierre-Yves Sage, Juliette Fischer, Marc Pocard, Catherine Arvieux, Fatah Tidadini
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0325941
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador
by: Kala Hickey, et al.
Published: (2025-04-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: D. D. Morikov, et al.
Published: (2022-05-01)

Cytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxoma
by: A. G. Abdullayev, et al.
Published: (2014-08-01)

Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022-01-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

Intraoperative photodynamic therapy and hyperthermic intraperitoneal chemotherapy in cytoreductive treatment of patients with disseminated mucinous carcinoma of appendix
by: D. V. Sidorov, et al.
Published: (2021-02-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study
by: Petersen Elisabeth Krogsgaard, et al.
Published: (2025-04-01)

Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
by: Hua-Hsi Wu, et al.
Published: (2025-08-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

On the Evaluation of the Hyperthermic Efficiency of Magnetic Scaffolds
by: Matteo B. Lodi, et al.
Published: (2024-01-01)

Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
by: Fu Lou, et al.
Published: (2025-08-01)

Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
by: Yan Wang, et al.
Published: (2025-08-01)

Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma
by: Viktor Proesmans, et al.
Published: (2022-12-01)

Implementation of an enhanced recovery after surgery (ERAS) program in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: study protocol for a prospective multicenter interventional trial (EPICH study)
by: Robella Manuela, et al.
Published: (2025-04-01)

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)
by: S. I. Radostev, et al.
Published: (2024-06-01)

The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPEC
by: Ghanipour Lana, et al.
Published: (2025-04-01)

The Involvement of Brain Monoamines in the Onset of Hyperthermic Central Fatigue
by: Coimbra, Cândido C., et al.
Published: (2012)

ALTERATION OF THERMAL BALANCE: HYPERTHERMIA, HYPERTHERMIC REACTIONS, HEAT STROKE, AND SUNSTROKE
by: P.F. Litvitskiy
Published: (2010-01-01)

PLA-b-PEG/magnetite hyperthermic agent prepared by Ugi four component condensation
by: L. P. Icart, et al.
Published: (2016-03-01)

Human Responses to Different Built Hyperthermal Environments After Short-Term Heat Acclimation
by: Shuai Zhang, et al.
Published: (2025-07-01)

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC
by: Somashekhar S. P., et al.
Published: (2025-05-01)

Specific features of current intraperitoneal therapy in patients with ovarian cancer
by: A. G. Kedrova, et al.
Published: (2016-06-01)

Intraperitoneal biotherapy of malignant peritoneal effusions in ovarian cancer patients
by: К. S. Titov, et al.
Published: (2014-07-01)

EFFICACY OF INTRAPERITONEAL INTERFERON-α ADMINISTRATION FOR TREATMENT OF ENDOMETRIOSIS IN RATS
by: R. V. Pavlov, et al.
Published: (2014-07-01)

Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
by: Sh. Kh. Gantsev, et al.
Published: (2019-04-01)

Comparison of the effects of three glyprolines after five days of intraperitoneal administration
by: A. A. Kolesnikova, et al.
Published: (2025-01-01)

LIVER TRANSPLANTATION FOR EPITHELIOID HEMANGIOENDOTHELIOMA WITH DIFFUSE INTRAPERITONEAL METASTASES: A CASE REPORT
by: I. A. Porshennikov, et al.
Published: (2014-05-01)

Intraperitoneal CHEMOPERFUSION TREATMENT OF ADVANCED OVARIAN CANCER WITH DIOXADET COMPARED TO CISPLATIN in experimental s
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Case Report: Iatrogenic intraperitoneal hematoma compresses the ureters leading to urogenic sepsis
by: Zhengyi Zhang, et al.
Published: (2025-07-01)

Laparoscopic intraperitoneal onlay mesh for pediatric incisional hernia—a case report
by: Maho Inoue, et al.
Published: (2017-12-01)

EXPERIMENTAL CONFIRMATION FOR SELECTION OF IRRADIATION REGIMENS FOR INTRAPERITONEAL PHOTODYNAMIC THERAPY WITH PORPHYRIN AND PHTHALOCYANINE PHOTOSENSITIZERS
by: A. A. Pankratov, et al.
Published: (2017-09-01)

Ascitic ovarian cancer is an adequate preclinical model of carcinomatosis to study intraperitoneal chemoperfusion treatment
by: G. S. Kireeva, et al.
Published: (2019-02-01)

Development of a nomogram for predicting the intraperitoneal rupture of necrotic collection in patients with necrotizing pancreatitis
by: Gang Li, et al.
Published: (2025-08-01)

Effect of intranasal and intraperitoneal administration of peptides Semax and Noopept on the behavior of BALB/c mice
by: E. V. Vasilieva, et al.
Published: (2016-03-01)

The effect of oral administration of NXP032 equivalent to intraperitoneal administration in an Alzheimer’s disease model
by: Jae Min Lee, et al.
Published: (2025-07-01)

EXPERIENCE WITH INTRAPERITONEAL CHEMOTHERAPY USING ASCITIC FLUID AS A SOLVENT OF CHEMICALS IN THE TREATMENT OF OVARIAN CANCER
by: Yu. S. Sidorenko, et al.
Published: (2014-09-01)